UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond
暂无分享,去创建一个
J. Romijn | E. Stroes | G. Dallinga-Thie | J. Kuivenhoven | M. Hoekstra | G. Hovingh | M. Motazacker | A. Bochem | A. Holleboom
[1] J. Romijn,et al. High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C , 2013, Journal of Lipid Research.
[2] Jan Albert Kuivenhoven,et al. Genetic variant of the scavenger receptor BI in humans. , 2011, The New England journal of medicine.
[3] W. Shen,et al. Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones , 2010, Nutrition & metabolism.
[4] N. Wareham,et al. Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study , 2010, Journal of Lipid Research.
[5] G. Franceschini,et al. Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans , 2009, Circulation.
[6] J. Kastelein,et al. In Vivo Quantification of Carotid Artery Wall Dimensions: 3.0-Tesla MRI Versus B-Mode Ultrasound Imaging , 2009, Circulation. Cardiovascular imaging.
[7] M. Hayden,et al. Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic β-Cell Dysfunction , 2008, Diabetes Care.
[8] T. V. van Berkel,et al. Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting Published, JLR Papers in Press, January 19, 2008. , 2008, Journal of Lipid Research.
[9] James D. Johnson,et al. β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment , 2007, Nature Medicine.
[10] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.
[11] M. Irwin,et al. Sex differences in the monocyte expression of IL-6: Role of autonomic mechanisms , 2006, Brain, Behavior, and Immunity.
[12] S. Doi,et al. Relationship between cortisol increment and basal cortisol: implications for the low-dose short adrenocorticotropic hormone stimulation test. , 2006, Clinical chemistry.
[13] P. Marik,et al. The hepatoadrenal syndrome: A common yet unrecognized clinical condition* , 2005, Critical care medicine.
[14] M. Kuiper,et al. HDL-cholesterol level and cortisol response to synacthen in critically ill patients. , 2003, Intensive care medicine.
[15] S. Azhar,et al. Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and 'selective' pathway connection. , 2003, Frontiers in bioscience : a journal and virtual library.
[16] S. Azhar,et al. Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis , 2002, Molecular and Cellular Endocrinology.
[17] R. Straub,et al. Differential Male and Female Adrenal Cortical Steroid Hormone and Cortisol Responses to Interleukin‐6 in Humans , 2002, Annals of the New York Academy of Sciences.
[18] B. McManus,et al. ABCA1 mRNA and Protein Distribution Patterns Predict Multiple Different Roles and Levels of Regulation , 2002, Laboratory Investigation.
[19] A. Zwinderman,et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study , 2002, The Lancet.
[20] J. Puder,et al. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. , 2001, The Journal of clinical endocrinology and metabolism.
[21] L. Muglia,et al. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Wardlaw,et al. Testosterone Suppresses the Response of the Hypothalamic-Pituitary-Adrenal Axis to Interleukin-6 , 2000, Neuroimmunomodulation.
[23] J. Connell,et al. Cortisol effects on body mass, blood pressure, and cholesterol in the general population. , 1999, Hypertension.
[24] Clark,et al. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic‐pituitary disorders , 1998, Clinical endocrinology.
[25] L. Blevins,et al. The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. , 1998, The Journal of clinical endocrinology and metabolism.
[26] H. Sasano,et al. Involvement of high density lipoprotein as substrate cholesterol for steroidogenesis by bovine adrenal fasciculo-reticularis cells. , 1998, Life sciences.
[27] W. Scherbaum,et al. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. , 1997, The Journal of clinical endocrinology and metabolism.
[28] B. Scheithauer,et al. Biochemical evaluation of adrenal dysfunction: the laboratory perspective. , 1992, Mayo Clinic proceedings.
[29] C. Weykamp,et al. Steroid profile for urine: reference values. , 1989, Clinical chemistry.
[30] S. Azhar,et al. Utilization of cholesterol-rich lipoproteins by perfused rat adrenals. , 1989, Journal of lipid research.
[31] J L Coolens,et al. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. , 1987, Journal of steroid biochemistry.
[32] F. Leidenberger,et al. Desensitization of mouse Leydig cells in vivo: evidence for the depletion of cellular cholesterol. , 1985, Biology of reproduction.
[33] Y. D. Chen,et al. Morphological evidence that high density lipoproteins are not internalized by steroid-producing cells during in situ organ perfusion. , 1984, The Journal of clinical investigation.
[34] D. Streeten,et al. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. , 1984, Endocrine reviews.
[35] R. Lees,et al. Adrenal cortical function in homozygous familial hypercholesterolemia. , 1983, Metabolism: clinical and experimental.
[36] G. Reaven,et al. Stimulation of lipoprotein receptors and role of lipoprotein and cellular cholesterol during gonadotropin-induced desensitization of steroidogenic response in luteinized rat ovary. , 1983, The Journal of biological chemistry.
[37] D. Illingworth,et al. Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH. , 1982, The Journal of laboratory and clinical medicine.
[38] D. Illingworth,et al. Impaired cortisol secretion in abetalipoproteinemia. , 1980, The Journal of clinical endocrinology and metabolism.
[39] R. Chanderbhan,et al. ACTH-induced hydrolysis of cholesteryl esters in rat adrenal cells. , 1978, Journal of lipid research.
[40] A. Borkowski,et al. Metabolism of adrenal cholesterol in man. I. In vivo studies. , 1972, The Journal of clinical investigation.
[41] N. A. Schmidt,et al. Profiling urinary steroids. A reliable procedure. , 1972, Clinica chimica acta; international journal of clinical chemistry.
[42] A. Mahler,et al. Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocorticotropin stimulation. , 1967, The Journal of clinical investigation.
[43] J. Kastelein,et al. Cholesterol Acyltransferase Gene Mutations Have Accelerated Atherogenesis as Assessed by Carotid 3.0-T Magnetic Resonance Imaging Carriers , 2011 .
[44] D. Illingworth,et al. Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia. , 1984, The Journal of clinical endocrinology and metabolism.
[45] D. Illingworth,et al. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. , 1982, The Journal of clinical endocrinology and metabolism.